

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * regulation of activation of Janus kinase activity (GO:0010533) | 9.35141154 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.50616233 |
| 3 | * negative regulation of interleukin-10 production (GO:0032693) | 6.37566003 |
| 4 | * positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 6.18669379 |
| 5 | * positive regulation of T-helper cell differentiation (GO:0045624) | 6.15616449 |
| 6 | kynurenine metabolic process (GO:0070189) | 6.04500003 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.83212740 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.83212740 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.83212740 |
| 10 | regulation of T-helper 2 cell differentiation (GO:0045628) | 5.68893965 |
| 11 | * positive regulation of interleukin-12 production (GO:0032735) | 5.46011411 |
| 12 | * regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 5.45823436 |
| 13 | positive regulation of type 2 immune response (GO:0002830) | 5.44734142 |
| 14 | regulation of immunoglobulin secretion (GO:0051023) | 5.41017264 |
| 15 | * regulation of memory T cell differentiation (GO:0043380) | 5.39342577 |
| 16 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.38212900 |
| 17 | * T-helper 1 type immune response (GO:0042088) | 5.19053011 |
| 18 | * positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.07961596 |
| 19 | * positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 5.07462637 |
| 20 | regulation of vitamin metabolic process (GO:0030656) | 5.06180493 |
| 21 | * positive regulation of NF-kappaB import into nucleus (GO:0042346) | 4.95140616 |
| 22 | positive regulation of neutrophil migration (GO:1902624) | 4.93721656 |
| 23 | positive regulation of neutrophil chemotaxis (GO:0090023) | 4.93721656 |
| 24 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.82403099 |
| 25 | * regulation of T-helper cell differentiation (GO:0045622) | 4.79304742 |
| 26 | type I interferon signaling pathway (GO:0060337) | 4.70236010 |
| 27 | cellular response to type I interferon (GO:0071357) | 4.70236010 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 4.69622229 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 4.68945823 |
| 30 | regulation of RIG-I signaling pathway (GO:0039535) | 4.64352864 |
| 31 | * regulation of alpha-beta T cell proliferation (GO:0046640) | 4.62395553 |
| 32 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.62346792 |
| 33 | natural killer cell mediated immunity (GO:0002228) | 4.62346792 |
| 34 | tryptophan metabolic process (GO:0006568) | 4.62140299 |
| 35 | response to type I interferon (GO:0034340) | 4.62104318 |
| 36 | positive regulation of heat generation (GO:0031652) | 4.61569283 |
| 37 | response to peptidoglycan (GO:0032494) | 4.56868764 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.43574657 |
| 39 | regulation of fever generation (GO:0031620) | 4.41767334 |
| 40 | regulation of interferon-alpha production (GO:0032647) | 4.37469283 |
| 41 | * positive regulation of interleukin-17 production (GO:0032740) | 4.34506140 |
| 42 | positive regulation of granulocyte chemotaxis (GO:0071624) | 4.32883318 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 4.29805256 |
| 44 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.28820743 |
| 45 | * positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 4.24213830 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.18426404 |
| 47 | neutrophil activation involved in immune response (GO:0002283) | 4.15355830 |
| 48 | regulation of neutrophil chemotaxis (GO:0090022) | 4.14364228 |
| 49 | regulation of neutrophil migration (GO:1902622) | 4.14364228 |
| 50 | eosinophil chemotaxis (GO:0048245) | 4.13474961 |
| 51 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.13187032 |
| 52 | * regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 4.12923341 |
| 53 | * regulation of interleukin-10 production (GO:0032653) | 4.12231866 |
| 54 | cellular biogenic amine catabolic process (GO:0042402) | 4.07688287 |
| 55 | amine catabolic process (GO:0009310) | 4.07688287 |
| 56 | monocyte chemotaxis (GO:0002548) | 4.06398445 |
| 57 | * regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 4.04781315 |
| 58 | * regulation of interleukin-12 production (GO:0032655) | 3.99445911 |
| 59 | regulation of hypersensitivity (GO:0002883) | 3.98156894 |
| 60 | regulation of tolerance induction (GO:0002643) | 3.96339622 |
| 61 | myeloid dendritic cell differentiation (GO:0043011) | 3.95791818 |
| 62 | granulocyte activation (GO:0036230) | 3.95148541 |
| 63 | neutrophil activation (GO:0042119) | 3.91379616 |
| 64 | natural killer cell differentiation (GO:0001779) | 3.91076966 |
| 65 | positive regulation of tolerance induction (GO:0002645) | 3.90227212 |
| 66 | * regulation of alpha-beta T cell differentiation (GO:0046637) | 3.89502324 |
| 67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.88902999 |
| 68 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.88813947 |
| 69 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.88344235 |
| 70 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.88307025 |
| 71 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.72742651 |
| 72 | * defense response to protozoan (GO:0042832) | 3.72159612 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.71999434 |
| 74 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.71815423 |
| 75 | negative regulation of viral genome replication (GO:0045071) | 3.68199283 |
| 76 | regulation of chemokine biosynthetic process (GO:0045073) | 3.67113563 |
| 77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.66671934 |
| 78 | regulation of heat generation (GO:0031650) | 3.65854502 |
| 79 | eosinophil migration (GO:0072677) | 3.63758285 |
| 80 | positive regulation of T cell cytokine production (GO:0002726) | 3.61998961 |
| 81 | * regulation of T-helper 1 type immune response (GO:0002825) | 3.60595733 |
| 82 | positive regulation of interleukin-2 production (GO:0032743) | 3.59294741 |
| 83 | * positive regulation of activated T cell proliferation (GO:0042104) | 3.58893367 |
| 84 | cellular response to ATP (GO:0071318) | 3.58233195 |
| 85 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.55795102 |
| 86 | * regulation of NF-kappaB import into nucleus (GO:0042345) | 3.52340421 |
| 87 | * regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.52249254 |
| 88 | * positive regulation of T-helper 1 type immune response (GO:0002827) | 3.51917393 |
| 89 | leukocyte mediated cytotoxicity (GO:0001909) | 3.50183540 |
| 90 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.48967040 |
| 91 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.47494588 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 3.47478159 |
| 93 | regulation of granulocyte chemotaxis (GO:0071622) | 3.46787607 |
| 94 | indolalkylamine metabolic process (GO:0006586) | 3.46476204 |
| 95 | * regulation of interleukin-17 production (GO:0032660) | 3.43136784 |
| 96 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.42895331 |
| 97 | * positive regulation of alpha-beta T cell activation (GO:0046635) | 3.41529300 |
| 98 | * regulation of natural killer cell activation (GO:0032814) | 3.41300659 |
| 99 | cellular response to interferon-alpha (GO:0035457) | 3.40968008 |
| 100 | * positive regulation of defense response to virus by host (GO:0002230) | 3.40484684 |
| 101 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.40123384 |
| 102 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.38235808 |
| 103 | response to interferon-alpha (GO:0035455) | 3.37345658 |
| 104 | * regulation of alpha-beta T cell activation (GO:0046634) | 3.36823520 |
| 105 | immunoglobulin mediated immune response (GO:0016064) | 3.35887097 |
| 106 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.35787941 |
| 107 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.34585564 |
| 108 | * positive regulation of interleukin-10 production (GO:0032733) | 3.31477219 |
| 109 | * positive regulation of T cell proliferation (GO:0042102) | 3.30547614 |
| 110 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.29218637 |
| 111 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26734381 |
| 112 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.26435983 |
| 113 | * positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.24717178 |
| 114 | * positive regulation of alpha-beta T cell differentiation (GO:0046638) | 3.24568005 |
| 115 | * positive regulation of osteoclast differentiation (GO:0045672) | 3.24484629 |
| 116 | cellular response to virus (GO:0098586) | 3.23200034 |
| 117 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.23191482 |
| 118 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23191482 |
| 119 | cellular response to interferon-beta (GO:0035458) | 3.21595816 |
| 120 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.21538837 |
| 121 | lymphocyte chemotaxis (GO:0048247) | 3.18678796 |
| 122 | cellular response to zinc ion (GO:0071294) | 3.18529478 |
| 123 | NIK/NF-kappaB signaling (GO:0038061) | 3.18442974 |
| 124 | positive regulation of protein kinase C signaling (GO:0090037) | 3.18398994 |
| 125 | positive regulation of interferon-beta production (GO:0032728) | 3.18237710 |
| 126 | dendritic cell differentiation (GO:0097028) | 3.18184196 |
| 127 | positive regulation of isotype switching (GO:0045830) | 3.17973466 |
| 128 | regulation of type 2 immune response (GO:0002828) | 3.17253545 |
| 129 | * positive regulation of natural killer cell activation (GO:0032816) | 3.16302435 |
| 130 | regulation of mononuclear cell migration (GO:0071675) | 3.16091880 |
| 131 | * positive regulation of T cell differentiation (GO:0045582) | 3.15708194 |
| 132 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.15537566 |
| 133 | * regulation of activated T cell proliferation (GO:0046006) | 3.13810157 |
| 134 | regulation of monocyte chemotaxis (GO:0090025) | 3.13045382 |
| 135 | regulation of chronic inflammatory response (GO:0002676) | 3.12249985 |
| 136 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.11160601 |
| 137 | response to muramyl dipeptide (GO:0032495) | 3.08770079 |
| 138 | dendritic cell chemotaxis (GO:0002407) | 3.08752509 |
| 139 | * regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.07889531 |
| 140 | regulation of podosome assembly (GO:0071801) | 3.07457041 |
| 141 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06962467 |
| 142 | positive regulation of humoral immune response (GO:0002922) | 3.06813175 |
| 143 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.05823297 |
| 144 | cellular response to exogenous dsRNA (GO:0071360) | 3.05367514 |
| 145 | * response to protozoan (GO:0001562) | 3.04744141 |
| 146 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.04494667 |
| 147 | positive regulation of T cell migration (GO:2000406) | 3.03692618 |
| 148 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.03383066 |
| 149 | regulation of T cell chemotaxis (GO:0010819) | 3.03319635 |
| 150 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01782762 |
| 151 | negative regulation of monooxygenase activity (GO:0032769) | 2.97615944 |
| 152 | vitamin catabolic process (GO:0009111) | 2.97107715 |
| 153 | fat-soluble vitamin catabolic process (GO:0042363) | 2.97107715 |
| 154 | * regulation of defense response to virus by host (GO:0050691) | 2.96079365 |
| 155 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.96025876 |
| 156 | * positive regulation of lymphocyte differentiation (GO:0045621) | 2.95843364 |
| 157 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94069729 |
| 158 | regulation of interleukin-1 secretion (GO:0050704) | 2.92270133 |
| 159 | * positive regulation of transcription factor import into nucleus (GO:0042993) | 2.87590226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.59128147 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.33098926 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.48322346 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.94166664 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.87949177 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.25248111 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.07564081 |
| 8 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.93047520 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.17320365 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16004198 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.10727338 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06703277 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.95324662 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.87621794 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.80927378 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.56172569 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49746728 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.40496041 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.35910732 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17200143 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11037955 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.05598302 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96316293 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89873507 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74183242 |
| 26 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.70269596 |
| 27 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.70269596 |
| 28 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.70269596 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70252943 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60655378 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45968987 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45896920 |
| 33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44062871 |
| 34 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43215547 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.42428912 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39489845 |
| 37 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37327057 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37080528 |
| 39 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32292463 |
| 40 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.31108503 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31079378 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29271404 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27821812 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.25215090 |
| 45 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25186678 |
| 46 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23198528 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22587462 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22199121 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18913689 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17891297 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12740042 |
| 52 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11698107 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10189625 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09532891 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08749110 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08288850 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05541695 |
| 58 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.04004813 |
| 59 | MYB_26560356_Chip-Seq_TH1_Human | 1.03005588 |
| 60 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02780621 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02674199 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02674199 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01773239 |
| 64 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00914902 |
| 65 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.98103869 |
| 66 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97818682 |
| 67 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97589935 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97210002 |
| 69 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96309670 |
| 70 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95603021 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94197316 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93608599 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93016024 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91485939 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91454362 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90227744 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89723975 |
| 78 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88659277 |
| 79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87889149 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87485114 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87406223 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87008774 |
| 83 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86822327 |
| 84 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86378910 |
| 85 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83358615 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82889408 |
| 87 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.82775758 |
| 88 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.82187721 |
| 89 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.81729199 |
| 90 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.80740157 |
| 91 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.79975341 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79968026 |
| 93 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.78291710 |
| 94 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78171586 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 0.77666865 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77277907 |
| 97 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.77178849 |
| 98 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.77155916 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.77142938 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75922475 |
| 101 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75384071 |
| 102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74917911 |
| 103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74535073 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.73933394 |
| 105 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.72968180 |
| 106 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.71947163 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71299795 |
| 108 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.70422588 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69266561 |
| 110 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.66221417 |
| 111 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65911902 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.65648396 |
| 113 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.65648396 |
| 114 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.65100718 |
| 115 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.63086950 |
| 116 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.58342161 |
| 117 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.57879158 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.57633444 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.57044908 |
| 120 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.56621251 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.56348031 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.55980655 |
| 123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.55106960 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.54920592 |
| 125 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.54852533 |
| 126 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.51370844 |
| 127 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.50664398 |
| 128 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.50133289 |
| 129 | MAF_26560356_Chip-Seq_TH2_Human | 0.49852474 |
| 130 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.49090939 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.48927980 |
| 132 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.47894103 |
| 133 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.47670393 |
| 134 | GATA3_26560356_Chip-Seq_TH1_Human | 0.47208472 |
| 135 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.46502226 |
| 136 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.45952928 |
| 137 | P300_19829295_ChIP-Seq_ESCs_Human | 0.44812431 |
| 138 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.44427835 |
| 139 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.44399409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.62842488 |
| 2 | * MP0009785_altered_susceptibility_to | 5.22925614 |
| 3 | * MP0002148_abnormal_hypersensitivity_rea | 4.60125564 |
| 4 | MP0005671_abnormal_response_to | 4.59127793 |
| 5 | MP0000685_abnormal_immune_system | 3.74997195 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.44576595 |
| 7 | MP0008004_abnormal_stomach_pH | 3.41714974 |
| 8 | MP0003436_decreased_susceptibility_to | 3.33581125 |
| 9 | MP0005387_immune_system_phenotype | 3.31404000 |
| 10 | MP0001790_abnormal_immune_system | 3.31404000 |
| 11 | * MP0005025_abnormal_response_to | 3.26147076 |
| 12 | MP0006082_CNS_inflammation | 3.14991539 |
| 13 | MP0003724_increased_susceptibility_to | 3.00588725 |
| 14 | * MP0002419_abnormal_innate_immunity | 2.79965773 |
| 15 | MP0004510_myositis | 2.78724672 |
| 16 | MP0001348_abnormal_lacrimal_gland | 2.68953152 |
| 17 | MP0001800_abnormal_humoral_immune | 2.60655873 |
| 18 | * MP0002723_abnormal_immune_serum | 2.60367895 |
| 19 | MP0009764_decreased_sensitivity_to | 2.54573444 |
| 20 | * MP0002452_abnormal_antigen_presenting | 2.54075729 |
| 21 | MP0003303_peritoneal_inflammation | 2.43611888 |
| 22 | MP0002006_tumorigenesis | 2.42137496 |
| 23 | * MP0001819_abnormal_immune_cell | 2.20251560 |
| 24 | MP0002163_abnormal_gland_morphology | 2.17475966 |
| 25 | MP0003195_calcinosis | 2.12432867 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 2.09760094 |
| 27 | MP0005451_abnormal_body_composition | 2.07741969 |
| 28 | MP0003448_altered_tumor_morphology | 2.02891084 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.92124322 |
| 30 | MP0004947_skin_inflammation | 1.78595227 |
| 31 | * MP0001845_abnormal_inflammatory_respons | 1.77485927 |
| 32 | MP0001346_abnormal_lacrimal_gland | 1.76006006 |
| 33 | MP0001853_heart_inflammation | 1.70969107 |
| 34 | * MP0008469_abnormal_protein_level | 1.67242109 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.66556934 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.66250368 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.63535707 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.61117808 |
| 39 | * MP0000716_abnormal_immune_system | 1.59156643 |
| 40 | MP0005310_abnormal_salivary_gland | 1.58823197 |
| 41 | * MP0010155_abnormal_intestine_physiology | 1.58617120 |
| 42 | * MP0002398_abnormal_bone_marrow | 1.45237036 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.39960552 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.39960552 |
| 45 | MP0003075_altered_response_to | 1.39390325 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.39205923 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.39164127 |
| 48 | MP0008057_abnormal_DNA_replication | 1.38838203 |
| 49 | MP0000858_altered_metastatic_potential | 1.36417863 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.29619738 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.24973007 |
| 52 | * MP0002405_respiratory_system_inflammati | 1.21849690 |
| 53 | MP0005379_endocrine/exocrine_gland_phen | 1.17477816 |
| 54 | * MP0002429_abnormal_blood_cell | 1.17350958 |
| 55 | MP0003300_gastrointestinal_ulcer | 1.16279971 |
| 56 | MP0003646_muscle_fatigue | 1.15776603 |
| 57 | MP0003186_abnormal_redox_activity | 1.13690228 |
| 58 | * MP0009763_increased_sensitivity_to | 1.13335770 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.12971920 |
| 60 | MP0003091_abnormal_cell_migration | 1.08643487 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.06807030 |
| 62 | MP0005166_decreased_susceptibility_to | 1.04414058 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.03632433 |
| 64 | MP0005164_abnormal_response_to | 1.00715942 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.96949301 |
| 66 | MP0005647_abnormal_sex_gland | 0.96066131 |
| 67 | MP0000343_altered_response_to | 0.95535654 |
| 68 | MP0000689_abnormal_spleen_morphology | 0.94832955 |
| 69 | MP0008874_decreased_physiological_sensi | 0.94127243 |
| 70 | MP0003690_abnormal_glial_cell | 0.94066471 |
| 71 | MP0002722_abnormal_immune_system | 0.92485837 |
| 72 | MP0001881_abnormal_mammary_gland | 0.91685772 |
| 73 | MP0009278_abnormal_bone_marrow | 0.90666566 |
| 74 | MP0005266_abnormal_metabolism | 0.85491321 |
| 75 | MP0005058_abnormal_lysosome_morphology | 0.85336898 |
| 76 | MP0001727_abnormal_embryo_implantation | 0.84778466 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.84212975 |
| 78 | MP0002735_abnormal_chemical_nociception | 0.81084104 |
| 79 | MP0002254_reproductive_system_inflammat | 0.78136006 |
| 80 | MP0005390_skeleton_phenotype | 0.77247611 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.76935700 |
| 82 | MP0001663_abnormal_digestive_system | 0.76349927 |
| 83 | MP0002736_abnormal_nociception_after | 0.75576311 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.74778629 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.74661682 |
| 86 | MP0000678_abnormal_parathyroid_gland | 0.74152933 |
| 87 | MP0000627_abnormal_mammary_gland | 0.73959919 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 0.72638853 |
| 89 | MP0010307_abnormal_tumor_latency | 0.72198331 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.72103755 |
| 91 | MP0005171_absent_coat_pigmentation | 0.70968967 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.67195783 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.66667870 |
| 94 | MP0000604_amyloidosis | 0.66088361 |
| 95 | MP0005623_abnormal_meninges_morphology | 0.64764454 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.64271806 |
| 97 | MP0004858_abnormal_nervous_system | 0.63146745 |
| 98 | MP0008875_abnormal_xenobiotic_pharmacok | 0.62251392 |
| 99 | MP0000249_abnormal_blood_vessel | 0.62021504 |
| 100 | MP0001919_abnormal_reproductive_system | 0.61947816 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.61049653 |
| 102 | MP0002168_other_aberrant_phenotype | 0.59459327 |
| 103 | MP0005410_abnormal_fertilization | 0.58452519 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.57898321 |
| 105 | * MP0009765_abnormal_xenobiotic_induced | 0.56482165 |
| 106 | MP0004484_altered_response_of | 0.56028768 |
| 107 | MP0005408_hypopigmentation | 0.54229579 |
| 108 | MP0000371_diluted_coat_color | 0.54147694 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.53484806 |
| 110 | MP0005535_abnormal_body_temperature | 0.52392851 |
| 111 | MP0006054_spinal_hemorrhage | 0.51830716 |
| 112 | MP0000920_abnormal_myelination | 0.50861360 |
| 113 | MP0001764_abnormal_homeostasis | 0.50781706 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.50582835 |
| 115 | MP0004742_abnormal_vestibular_system | 0.50436874 |
| 116 | MP0009840_abnormal_foam_cell | 0.49256723 |
| 117 | MP0008873_increased_physiological_sensi | 0.49157503 |
| 118 | MP0010234_abnormal_vibrissa_follicle | 0.44810788 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.43642605 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.43455268 |
| 121 | MP0003941_abnormal_skin_development | 0.43309939 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43238560 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.43214442 |
| 124 | MP0004883_abnormal_blood_vessel | 0.42041704 |
| 125 | MP0000703_abnormal_thymus_morphology | 0.40290825 |
| 126 | MP0003045_fibrosis | 0.39830148 |
| 127 | MP0010352_gastrointestinal_tract_polyps | 0.38496281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 8.51346630 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.96897152 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.64416780 |
| 4 | Recurrent abscess formation (HP:0002722) | 6.43964514 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 6.27593663 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.56481011 |
| 7 | Generalized aminoaciduria (HP:0002909) | 5.23020762 |
| 8 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.19252927 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 5.11807962 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.11807962 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.11807962 |
| 12 | Hypergammaglobulinemia (HP:0010702) | 4.86487837 |
| 13 | Thin bony cortex (HP:0002753) | 4.72875404 |
| 14 | Enlarged epiphyses (HP:0010580) | 4.63389504 |
| 15 | Abnormality of macrophages (HP:0004311) | 4.52301454 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.42520559 |
| 17 | Hematochezia (HP:0002573) | 4.30224934 |
| 18 | Basal ganglia calcification (HP:0002135) | 4.29098442 |
| 19 | Recurrent skin infections (HP:0001581) | 4.27613768 |
| 20 | Gingivitis (HP:0000230) | 4.17604086 |
| 21 | Stomatitis (HP:0010280) | 4.07773216 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 4.06416633 |
| 23 | Recurrent fungal infections (HP:0002841) | 4.03494223 |
| 24 | Delayed epiphyseal ossification (HP:0002663) | 4.00812076 |
| 25 | Recurrent viral infections (HP:0004429) | 4.00071790 |
| 26 | Abnormality of the costochondral junction (HP:0000919) | 3.99016251 |
| 27 | Optic neuritis (HP:0100653) | 3.94621400 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.94621400 |
| 29 | Metaphyseal irregularity (HP:0003025) | 3.93105641 |
| 30 | * Vasculitis (HP:0002633) | 3.89259133 |
| 31 | * Gastrointestinal infarctions (HP:0005244) | 3.82185508 |
| 32 | Widely patent fontanelles and sutures (HP:0004492) | 3.76352455 |
| 33 | Symptomatic seizures (HP:0011145) | 3.75662551 |
| 34 | Thick nail (HP:0001805) | 3.75034612 |
| 35 | Periodontitis (HP:0000704) | 3.74349728 |
| 36 | IgA deficiency (HP:0002720) | 3.71999274 |
| 37 | Orchitis (HP:0100796) | 3.71035328 |
| 38 | Porencephaly (HP:0002132) | 3.65010991 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 3.58801516 |
| 40 | Myositis (HP:0100614) | 3.52238694 |
| 41 | Chronic otitis media (HP:0000389) | 3.46301988 |
| 42 | Flat occiput (HP:0005469) | 3.45824843 |
| 43 | Interstitial pulmonary disease (HP:0006530) | 3.43829169 |
| 44 | Pustule (HP:0200039) | 3.41666174 |
| 45 | Tetraparesis (HP:0002273) | 3.31492913 |
| 46 | Arterial thrombosis (HP:0004420) | 3.21064044 |
| 47 | Dysostosis multiplex (HP:0000943) | 3.20655857 |
| 48 | Cellulitis (HP:0100658) | 3.16240765 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 3.07840488 |
| 50 | Obstructive lung disease (HP:0006536) | 3.07840488 |
| 51 | Pulmonary infiltrates (HP:0002113) | 3.07024127 |
| 52 | Protuberant abdomen (HP:0001538) | 3.06965515 |
| 53 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01930484 |
| 54 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01930484 |
| 55 | Increased serum ferritin (HP:0003281) | 2.99516717 |
| 56 | Joint swelling (HP:0001386) | 2.98175234 |
| 57 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.93006046 |
| 58 | Lower limb hyperreflexia (HP:0002395) | 2.91683960 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.90632284 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83826768 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83826768 |
| 62 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83826768 |
| 63 | Premature loss of primary teeth (HP:0006323) | 2.82152343 |
| 64 | Gingival bleeding (HP:0000225) | 2.81459114 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.76337035 |
| 66 | B lymphocytopenia (HP:0010976) | 2.75753662 |
| 67 | IgG deficiency (HP:0004315) | 2.75335585 |
| 68 | Cerebral hemorrhage (HP:0001342) | 2.72149111 |
| 69 | Osteolytic defects of the hand bones (HP:0009699) | 2.71417220 |
| 70 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.71417220 |
| 71 | Peritonitis (HP:0002586) | 2.70721290 |
| 72 | Myocardial infarction (HP:0001658) | 2.69402937 |
| 73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68906697 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.68906697 |
| 75 | Recurrent pneumonia (HP:0006532) | 2.66551876 |
| 76 | Meningitis (HP:0001287) | 2.65113791 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 2.61973273 |
| 78 | Increased cerebral lipofuscin (HP:0011813) | 2.60081990 |
| 79 | Abnormality of iron homeostasis (HP:0011031) | 2.58908933 |
| 80 | Abnormality of the pericardium (HP:0001697) | 2.57428187 |
| 81 | Agammaglobulinemia (HP:0004432) | 2.57421818 |
| 82 | * Gangrene (HP:0100758) | 2.54065220 |
| 83 | Chronic sinusitis (HP:0011109) | 2.52667055 |
| 84 | Leukocytosis (HP:0001974) | 2.51194290 |
| 85 | Thrombocytosis (HP:0001894) | 2.50542853 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.49593094 |
| 87 | Urticaria (HP:0001025) | 2.49277127 |
| 88 | Nasal polyposis (HP:0100582) | 2.48245483 |
| 89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.47167334 |
| 90 | Loss of speech (HP:0002371) | 2.41429634 |
| 91 | Recurrent bronchitis (HP:0002837) | 2.41228072 |
| 92 | Cleft eyelid (HP:0000625) | 2.40572477 |
| 93 | T lymphocytopenia (HP:0005403) | 2.40334581 |
| 94 | Disinhibition (HP:0000734) | 2.39607821 |
| 95 | Osteomyelitis (HP:0002754) | 2.38868242 |
| 96 | Stomach cancer (HP:0012126) | 2.37164118 |
| 97 | Neutropenia (HP:0001875) | 2.35025423 |
| 98 | Esophageal varix (HP:0002040) | 2.32212278 |
| 99 | Abnormality of the pleura (HP:0002103) | 2.30653274 |
| 100 | Albinism (HP:0001022) | 2.29948339 |
| 101 | Abnormality of the nasal mucosa (HP:0000433) | 2.25511085 |
| 102 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24894981 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 2.24383593 |
| 104 | Hyperphosphatemia (HP:0002905) | 2.21694900 |
| 105 | Encephalitis (HP:0002383) | 2.21685108 |
| 106 | Axonal loss (HP:0003447) | 2.20340184 |
| 107 | Keratitis (HP:0000491) | 2.16872413 |
| 108 | Rickets (HP:0002748) | 2.16380120 |
| 109 | Eosinophilia (HP:0001880) | 2.12621911 |
| 110 | Hyperparathyroidism (HP:0000843) | 2.11887376 |
| 111 | Purpura (HP:0000979) | 2.07351437 |
| 112 | Plagiocephaly (HP:0001357) | 2.07130517 |
| 113 | * Arthralgia (HP:0002829) | 2.05339609 |
| 114 | Petechiae (HP:0000967) | 2.04760660 |
| 115 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04747759 |
| 116 | Sepsis (HP:0100806) | 2.03961444 |
| 117 | Poor head control (HP:0002421) | 2.03331639 |
| 118 | Abnormality of T cells (HP:0002843) | 2.03200969 |
| 119 | Keratoconjunctivitis (HP:0001096) | 2.02413155 |
| 120 | Mutism (HP:0002300) | 2.02283074 |
| 121 | * Hemoptysis (HP:0002105) | 2.01520117 |
| 122 | Femoral bowing (HP:0002980) | 2.01240084 |
| 123 | Parakeratosis (HP:0001036) | 2.00989430 |
| 124 | Tinnitus (HP:0000360) | 2.00715316 |
| 125 | Combined immunodeficiency (HP:0005387) | 1.98281463 |
| 126 | Apathy (HP:0000741) | 1.98204622 |
| 127 | Abnormality of the basal ganglia (HP:0002134) | 1.97732650 |
| 128 | Spastic tetraparesis (HP:0001285) | 1.97240566 |
| 129 | Polyneuropathy (HP:0001271) | 1.96372641 |
| 130 | Spontaneous hematomas (HP:0007420) | 1.93945382 |
| 131 | Hypophosphatemia (HP:0002148) | 1.92863764 |
| 132 | Colitis (HP:0002583) | 1.90793487 |
| 133 | Diminished motivation (HP:0000745) | 1.90635205 |
| 134 | Increased IgE level (HP:0003212) | 1.90047224 |
| 135 | Abnormality of eosinophils (HP:0001879) | 1.88798754 |
| 136 | Nephritis (HP:0000123) | 1.88122688 |
| 137 | Progressive visual loss (HP:0000529) | 1.88096175 |
| 138 | Spontaneous abortion (HP:0005268) | 1.86467360 |
| 139 | * Cerebral ischemia (HP:0002637) | 1.84450521 |
| 140 | * Skin ulcer (HP:0200042) | 1.84319523 |
| 141 | Polycythemia (HP:0001901) | 1.83507026 |
| 142 | Abnormality of T cell physiology (HP:0011840) | 1.81752256 |
| 143 | Prolonged neonatal jaundice (HP:0006579) | 1.81540026 |
| 144 | Chronic diarrhea (HP:0002028) | 1.81037898 |
| 145 | Abnormal trabecular bone morphology (HP:0100671) | 1.80551691 |
| 146 | Vacuolated lymphocytes (HP:0001922) | 1.80449974 |
| 147 | Prostate neoplasm (HP:0100787) | 1.78924099 |
| 148 | Vertigo (HP:0002321) | 1.78883651 |
| 149 | Thrombophlebitis (HP:0004418) | 1.77188666 |
| 150 | Progressive neurologic deterioration (HP:0002344) | 1.75268929 |
| 151 | Thyroiditis (HP:0100646) | 1.74370402 |
| 152 | Nuclear cataract (HP:0100018) | 1.74130767 |
| 153 | Alveolar cell carcinoma (HP:0006519) | 1.73574403 |
| 154 | Nausea (HP:0002018) | 1.71080189 |
| 155 | Episodic fever (HP:0001954) | 1.70663055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.97364790 |
| 2 | PBK | 4.59886601 |
| 3 | TBK1 | 3.98534503 |
| 4 | JAK3 | 3.69905719 |
| 5 | TYK2 | 3.60382157 |
| 6 | RIPK4 | 3.52598374 |
| 7 | MAP3K13 | 3.39271255 |
| 8 | IKBKB | 3.26131295 |
| 9 | PIM2 | 3.09937570 |
| 10 | IRAK4 | 2.84550439 |
| 11 | DDR2 | 2.83126718 |
| 12 | IKBKE | 2.71219592 |
| 13 | JAK1 | 2.52979922 |
| 14 | CHUK | 2.31586099 |
| 15 | ARAF | 2.31279338 |
| 16 | ACVR1B | 1.96211960 |
| 17 | NEK9 | 1.94193213 |
| 18 | MST4 | 1.91874399 |
| 19 | BLK | 1.89148991 |
| 20 | TAOK2 | 1.82596264 |
| 21 | FRK | 1.80271577 |
| 22 | BMPR2 | 1.73710566 |
| 23 | PRPF4B | 1.73220815 |
| 24 | EPHA3 | 1.65806875 |
| 25 | IRAK3 | 1.58960531 |
| 26 | FGFR4 | 1.46743269 |
| 27 | SYK | 1.37284718 |
| 28 | STK4 | 1.32754142 |
| 29 | EPHB1 | 1.31766523 |
| 30 | CLK1 | 1.27983023 |
| 31 | MAP3K9 | 1.24133276 |
| 32 | TYRO3 | 1.21060744 |
| 33 | JAK2 | 1.20919871 |
| 34 | EIF2AK2 | 1.19927908 |
| 35 | ERBB3 | 1.19843545 |
| 36 | IRAK1 | 1.08751474 |
| 37 | MAP4K1 | 1.05131659 |
| 38 | TRPM7 | 1.03919079 |
| 39 | CDC42BPA | 1.03126744 |
| 40 | HCK | 1.01271504 |
| 41 | ABL2 | 1.00924615 |
| 42 | MAP4K2 | 0.95930850 |
| 43 | TXK | 0.94958637 |
| 44 | MAP3K3 | 0.93423402 |
| 45 | KIT | 0.91141526 |
| 46 | FGFR3 | 0.90565899 |
| 47 | CSK | 0.90121005 |
| 48 | PRKCQ | 0.87130598 |
| 49 | LCK | 0.86440941 |
| 50 | PIM1 | 0.81462799 |
| 51 | ZAP70 | 0.81146687 |
| 52 | MKNK1 | 0.80770838 |
| 53 | TESK1 | 0.79708452 |
| 54 | BCKDK | 0.79702701 |
| 55 | ADRBK2 | 0.75920268 |
| 56 | LYN | 0.74216864 |
| 57 | BTK | 0.72355998 |
| 58 | DAPK3 | 0.71784518 |
| 59 | MAPKAPK5 | 0.71439545 |
| 60 | MOS | 0.70672616 |
| 61 | BCR | 0.69799300 |
| 62 | PKN1 | 0.69459711 |
| 63 | GRK7 | 0.68403938 |
| 64 | ZAK | 0.68161832 |
| 65 | WNK3 | 0.67992925 |
| 66 | FES | 0.67363005 |
| 67 | TAOK3 | 0.66368466 |
| 68 | PRKCD | 0.65918650 |
| 69 | CSF1R | 0.65398280 |
| 70 | SIK3 | 0.63614388 |
| 71 | LRRK2 | 0.62880760 |
| 72 | STK3 | 0.61695476 |
| 73 | MAP3K11 | 0.60342429 |
| 74 | EIF2AK3 | 0.59896780 |
| 75 | BMX | 0.58663701 |
| 76 | STK39 | 0.58358201 |
| 77 | YES1 | 0.57587822 |
| 78 | KSR2 | 0.57185160 |
| 79 | MARK3 | 0.55972962 |
| 80 | ABL1 | 0.55908538 |
| 81 | RPS6KA4 | 0.53910433 |
| 82 | WNK4 | 0.53867590 |
| 83 | MAP2K6 | 0.53435666 |
| 84 | MAP3K5 | 0.53069939 |
| 85 | PINK1 | 0.52526661 |
| 86 | MST1R | 0.50317123 |
| 87 | MATK | 0.49653230 |
| 88 | PLK2 | 0.47435882 |
| 89 | EGFR | 0.46324954 |
| 90 | NTRK1 | 0.45619729 |
| 91 | IRAK2 | 0.44241238 |
| 92 | MAP3K4 | 0.44205490 |
| 93 | MAP3K12 | 0.43160892 |
| 94 | PTK2B | 0.42770450 |
| 95 | WNK1 | 0.42452154 |
| 96 | NUAK1 | 0.42251060 |
| 97 | RIPK1 | 0.42014694 |
| 98 | PRKCE | 0.41898343 |
| 99 | NLK | 0.39340798 |
| 100 | HIPK2 | 0.38812536 |
| 101 | DAPK2 | 0.37105094 |
| 102 | ALK | 0.37044470 |
| 103 | INSRR | 0.36773740 |
| 104 | RPS6KA5 | 0.35684018 |
| 105 | TLK1 | 0.34795311 |
| 106 | EPHB2 | 0.32020765 |
| 107 | ERN1 | 0.29874405 |
| 108 | MAPKAPK2 | 0.29325927 |
| 109 | RAF1 | 0.29205564 |
| 110 | DYRK3 | 0.28544883 |
| 111 | MAPK4 | 0.28493902 |
| 112 | RET | 0.28333220 |
| 113 | FGR | 0.26727620 |
| 114 | IGF1R | 0.26682865 |
| 115 | DYRK1B | 0.25650427 |
| 116 | SIK2 | 0.25460648 |
| 117 | PDK1 | 0.23826209 |
| 118 | BRAF | 0.23775560 |
| 119 | PRKAA2 | 0.23397157 |
| 120 | RPS6KA1 | 0.23236989 |
| 121 | SRC | 0.23022557 |
| 122 | GSK3A | 0.22586093 |
| 123 | NME2 | 0.22162966 |
| 124 | FLT3 | 0.21745402 |
| 125 | PRKACG | 0.21703640 |
| 126 | MAP3K1 | 0.19643103 |
| 127 | PAK6 | 0.19339758 |
| 128 | DYRK2 | 0.18963324 |
| 129 | ERBB4 | 0.18734001 |
| 130 | STK38 | 0.17270306 |
| 131 | MAPK3 | 0.17267195 |
| 132 | TEC | 0.16001880 |
| 133 | MAP2K7 | 0.15795000 |
| 134 | STK24 | 0.15309031 |
| 135 | KSR1 | 0.14503696 |
| 136 | CDK15 | 0.14345953 |
| 137 | CDK18 | 0.14050239 |
| 138 | INSR | 0.13353789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.64561434 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 4.26081926 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.34257240 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.28365573 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.20131856 |
| 6 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.97965559 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.80655623 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.71599424 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.65423411 |
| 10 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.53293913 |
| 11 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.44521835 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.40746663 |
| 13 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.38402341 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.38238390 |
| 15 | * Measles_Homo sapiens_hsa05162 | 2.29031514 |
| 16 | * Pertussis_Homo sapiens_hsa05133 | 2.26034977 |
| 17 | Malaria_Homo sapiens_hsa05144 | 2.23088518 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.05684826 |
| 19 | * Influenza A_Homo sapiens_hsa05164 | 2.02650507 |
| 20 | * Legionellosis_Homo sapiens_hsa05134 | 2.01312402 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.96734856 |
| 22 | * African trypanosomiasis_Homo sapiens_hsa05143 | 1.93889280 |
| 23 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84800300 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70502447 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68079846 |
| 26 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.66438951 |
| 27 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.62557278 |
| 28 | * Tuberculosis_Homo sapiens_hsa05152 | 1.53396673 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52982386 |
| 30 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.49306366 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.46852539 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42057984 |
| 33 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33487538 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.31148172 |
| 35 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26358317 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17744336 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.16775789 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15974678 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06193014 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 0.96573983 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 0.95139584 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 0.94764330 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94658726 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93286683 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.88970386 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82905564 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81416745 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81304684 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80577402 |
| 50 | Proteasome_Homo sapiens_hsa03050 | 0.77617520 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76907686 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76653900 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75719750 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71349477 |
| 55 | * Amoebiasis_Homo sapiens_hsa05146 | 0.71270746 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62487115 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57992852 |
| 58 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57819699 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57608689 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53492559 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52567220 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50941308 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50734196 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50530528 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49961295 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48246993 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44609254 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42323733 |
| 69 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41023151 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36373635 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.36270354 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33974107 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33847690 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33267304 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33057072 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32864497 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29550103 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29492588 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29445845 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27394421 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26340203 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26142140 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.25925050 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.25742848 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.25740791 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.24369517 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24221727 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23605327 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22249258 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22128150 |
| 91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20973541 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.18057262 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15629387 |
| 94 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.14510761 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13057689 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.13002733 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.12307530 |
| 98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.12014194 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.11468540 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.11350446 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09994642 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.07835348 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07493365 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.07166017 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.06552533 |
| 106 | Phototransduction_Homo sapiens_hsa04744 | 0.06080333 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.05627948 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04278171 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.03868991 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.03725826 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.03680797 |
| 112 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.03532074 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.03099976 |
| 114 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.02855002 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.02795144 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.02626625 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.02305724 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | -0.0296429 |
| 119 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | -0.0131975 |
| 120 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0102421 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | -0.0064896 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | -0.0033124 |

